Stay updated on Subcutaneous Nivolumab + rHuPH20 Clinical Trial
Sign up to get notified when there's something new on the Subcutaneous Nivolumab + rHuPH20 Clinical Trial page.

Latest updates to the Subcutaneous Nivolumab + rHuPH20 Clinical Trial page
- Check3 days agoChange DetectedThe page's revision label has been updated to v3.5.5, signaling a small software update to the site rather than changes to the study details.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing v3.5.3, indicating a minor template/metadata update to the study details page. This adjustment does not alter the study information displayed.SummaryDifference0.0%

- Check46 days agoChange DetectedThis update refreshes the ClinicalTrials.gov page’s revision/version label (v3.5.3), without changing the study’s substantive details.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check67 days agoChange DetectedPadua, Italy, 35128 was replaced with Padova, Italy, 35128 in the locations list.SummaryDifference0.0%

- Check82 days agoChange DetectedRevision: v3.5.0 has been added and Revision: v3.4.3 has been removed. This appears to be a UI/version update with no changes to study data or content.SummaryDifference0.0%

Stay in the know with updates to Subcutaneous Nivolumab + rHuPH20 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Subcutaneous Nivolumab + rHuPH20 Clinical Trial page.